CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)

NCT00219973 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

526

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer
Venous Thromboembolism

Interventions

DRUG: Bemiparin

Sponsor

Rovi Pharmaceuticals Laboratories